184 related articles for article (PubMed ID: 28054368)
1. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.
Wei L; Ratnayake L; Phillips G; McGuigan CC; Morant SV; Flynn RW; Mackenzie IS; MacDonald TM
Br J Clin Pharmacol; 2017 Jun; 83(6):1298-1308. PubMed ID: 28054368
[TBL] [Abstract][Full Text] [Related]
2. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
[TBL] [Abstract][Full Text] [Related]
3. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.
García Rodríguez LA; Ruigómez A; Panés J
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1418-23. PubMed ID: 18054750
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
5. Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?
Garcia Rodríguez LA; Ruigómez A
Epidemiology; 1997 Sep; 8(5):571-4. PubMed ID: 9270961
[TBL] [Abstract][Full Text] [Related]
6. Case-control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection.
Bruijnesteijn van Coppenraet LE; Dullaert-de Boer M; Ruijs GJ; van der Reijden WA; van der Zanden AG; Weel JF; Schuurs TA
Clin Microbiol Infect; 2015 Jun; 21(6):592.e9-19. PubMed ID: 25700890
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
8. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
[TBL] [Abstract][Full Text] [Related]
9. Impact of the SARS-CoV-2 Pandemic on Prevalence and Incidence of Bacterial Gastroenteritis in Spain, 2019-2022.
Maldonado-Barrueco A; García-Rodríguez J; Ruiz-Carrascoso G
Foodborne Pathog Dis; 2024 May; 21(5):279-287. PubMed ID: 38271584
[TBL] [Abstract][Full Text] [Related]
10. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
11. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
Stevens V; Dumyati G; Brown J; Wijngaarden E
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
[TBL] [Abstract][Full Text] [Related]
12. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
14. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
[TBL] [Abstract][Full Text] [Related]
15. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
16. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
17. FilmArray™ GI panel performance for the diagnosis of acute gastroenteritis or hemorragic diarrhea.
Piralla A; Lunghi G; Ardissino G; Girello A; Premoli M; Bava E; Arghittu M; Colombo MR; Cognetto A; Bono P; Campanini G; Marone P; Baldanti F
BMC Microbiol; 2017 May; 17(1):111. PubMed ID: 28494766
[TBL] [Abstract][Full Text] [Related]
18. Association of Clostridium difficile infections with acid suppression medications in children.
Nylund CM; Eide M; Gorman GH
J Pediatr; 2014 Nov; 165(5):979-84.e1. PubMed ID: 25112692
[TBL] [Abstract][Full Text] [Related]
19. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991-2001.
van Pelt W; de Wit MA; Wannet WJ; Ligtvoet EJ; Widdowson MA; van Duynhoven YT
Epidemiol Infect; 2003 Jun; 130(3):431-41. PubMed ID: 12825727
[TBL] [Abstract][Full Text] [Related]
20. Bacterial gastroenteritis among hospitalized patients in a Danish County, 1991-93.
Petersen AM; Nielsen SV; Meyer D; Ganer P; Ladefoged K
Scand J Gastroenterol; 1996 Sep; 31(9):906-11. PubMed ID: 8888439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
